Adam R. Craig - 09 Nov 2022 Form 4 Insider Report for CTI BIOPHARMA CORP

Role: President and CEO, Director
Signature: Adam R. Craig
Issuer symbol: N/A
Transactions as of: 09 Nov 2022
Net transactions value: -$1,250,961
Form type: 4
Filing time: 14 Nov 2022, 15:42:55 UTC
Previous filing: 14 Sep 2022
Next filing: 03 Jan 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CTIC	common stock	Options Exercise	$45,416	+53,996	+194%	$0.8411^*	81,857	09 Nov 2022	Direct
transaction	CTIC	common stock	Sale	$276,600	-46,100	-56%	$6.00	35,757	09 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$45,652	-7,596	-21%	$6.01	28,161	09 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$1,804	-300	-1.1%	$6.02	27,861	09 Nov 2022	Direct	F1
transaction	CTIC	common stock	Options Exercise	$158,382	+188,304	+676%	$0.8411^*	216,165	10 Nov 2022	Direct
transaction	CTIC	common stock	Sale	$818,448	-136,408	-63%	$6.00	79,757	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$1,201	-200	-0.25%	$6.00	79,557	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$160,467	-26,700	-34%	$6.01	52,857	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$602	-100	-0.19%	$6.02	52,757	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$98,704	-16,396	-31%	$6.02	36,361	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$34,974	-5,800	-16%	$6.03	30,561	10 Nov 2022	Direct	F1
transaction	CTIC	common stock	Sale	$16,308	-2,700	-8.8%	$6.04	27,861	10 Nov 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTIC	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-53,996	-5.9%	$0.000000	859,258	09 Nov 2022	Common Stock	53,996	$0.8411	Direct	F2
transaction	CTIC	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-188,304	-22%	$0.000000	670,954	10 Nov 2022	Common Stock	188,304	$0.8411	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person.
F2	One third of the shares underlying the option vested on 2/19/20 and annually thereafter until all the underlying shares were fully vested on 2/19/2022.